Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daily vs weekly calcidiol dosing in postmenopausal women with vitamin D deficiency
2013-002648-10Phase 3Completed
- Sponsor
- Bruno Farmaceutici
- Start
- Feb 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of calcifediol in Vitamin D deficiency (VDD) (3 arms), sponsored by Bruno Farmaceutici. Primary endpoint: Circulating values of 25(OH)D3 at 3 months of treatment. Started Feb 2014; status: completed.
02
Drugs
calcifediol
03
Conditions
Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on 2013-002648-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002648-10.